United States · Series A startup

Who invested in Mekonos

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$25Mraised across 1 round since 2021, from 1 source

Latest round
Series A, $25MNov 2021
Investors
5
See who backed them

The rounds

  1. Nov 2021
    Series A$25M

    Source recordedSEC filing: $25M sold, first sale Oct 2021

Everyone who backed them

Creative Destruction LabAccelerator1round
NovartisVC firm1round
Sands Capital VenturesPrivate equity1round
S32VC firm1round
TDK VenturesCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Mekonos

Who invested in Mekonos?

Mekonos's investors include Creative Destruction Lab, Novartis, Sands Capital Ventures, S32 and TDK Ventures.

How much has Mekonos raised?

Mekonos has raised $25M across 1 round since 2021.

When did Mekonos last raise?

Mekonos's most recent round was a Series A of $25M in Nov 2021.

What was Mekonos's biggest round?

Its most recent round, $25M in Nov 2021, is also its largest on record.

Who backed Mekonos first?

Mekonos's first round on record, in Nov 2021, was backed by Creative Destruction Lab, Novartis and Sands Capital Ventures and 2 others.

What stage is Mekonos at?

Mekonos's latest named round is a Series A, in Nov 2021.

Where is Mekonos based?

Mekonos is based in the United States.

Companies like Mekonos

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.